Questcor Pharmacueticals (QCOR) Tops Q3 EPS by 20c

Questcor Pharmacueticals (NASDAQ: QCOR) reported Q3 EPS of $0.97, $0.20 better than the analyst estimate of $0.77. Revenue for the quarter came in at $140.3 million versus the consensus estimate of $128.97 million.

For earnings history and earnings-related data on Questcor Pharmacueticals (QCOR) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recover
• RCM Technologies (RCMT) Tops Q2 EPS by 17c